1. Home
  2. NAII vs XGN Comparison

NAII vs XGN Comparison

Compare NAII & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • XGN
  • Stock Information
  • Founded
  • NAII 1980
  • XGN N/A
  • Country
  • NAII United States
  • XGN United States
  • Employees
  • NAII N/A
  • XGN N/A
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • XGN Medical Specialities
  • Sector
  • NAII Health Care
  • XGN Health Care
  • Exchange
  • NAII Nasdaq
  • XGN Nasdaq
  • Market Cap
  • NAII 36.5M
  • XGN 33.9M
  • IPO Year
  • NAII 1987
  • XGN 2019
  • Fundamental
  • Price
  • NAII $5.79
  • XGN $1.99
  • Analyst Decision
  • NAII
  • XGN Buy
  • Analyst Count
  • NAII 0
  • XGN 1
  • Target Price
  • NAII N/A
  • XGN $7.00
  • AVG Volume (30 Days)
  • NAII 4.2K
  • XGN 20.0K
  • Earning Date
  • NAII 05-14-2024
  • XGN 08-05-2024
  • Dividend Yield
  • NAII N/A
  • XGN N/A
  • EPS Growth
  • NAII N/A
  • XGN N/A
  • EPS
  • NAII N/A
  • XGN N/A
  • Revenue
  • NAII $120,201,000.00
  • XGN $55,733,000.00
  • Revenue This Year
  • NAII N/A
  • XGN $7.16
  • Revenue Next Year
  • NAII N/A
  • XGN $16.16
  • P/E Ratio
  • NAII N/A
  • XGN N/A
  • Revenue Growth
  • NAII N/A
  • XGN 20.12
  • 52 Week Low
  • NAII $5.06
  • XGN $1.30
  • 52 Week High
  • NAII $7.62
  • XGN $2.95
  • Technical
  • Relative Strength Index (RSI)
  • NAII 45.47
  • XGN 54.76
  • Support Level
  • NAII $5.63
  • XGN $1.81
  • Resistance Level
  • NAII $5.89
  • XGN $2.21
  • Average True Range (ATR)
  • NAII 0.14
  • XGN 0.11
  • MACD
  • NAII 0.03
  • XGN 0.01
  • Stochastic Oscillator
  • NAII 72.73
  • XGN 56.00

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: